WCN26-8923 COMPARATIVE OUTCOMES OF APIXABAN VERSUS WARFARIN INITIATION IN PATIENTS ON HEMODIALYSIS WITH NEWLY DIAGNOSED ATRIAL FIBRILLATION

Read full text Summarise with VIRAT
Authors: Wolfgang C. Winkelmayer, Kevin F. Erickson, Tara I. Chang, Jingbo Niu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

An increasing number of patients with kidney failure on hemodialysis (HD), who are newly diagnosed with atrial fibrillation (AF), initiate oral anticoagulation, mostly using warfarin or apixaban. We sought to compare the outcomes of patients initiating the vitamin K antagonist, warfarin, to those initiating the factor Xa inhibitor, apixaban.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Venous Thromboembolism Diagnosis and Management Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104952–104952
Publication date
25 March 2026
Language
EN